Collegium Pharma (COLL) Tops Q2 EPS by 2c

Collegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.40), $0.02 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $73.1 million versus the consensus estimate of $72.2 million.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins